Medacta gained CE Mark approval for several of its sports medicine devices, and marked multiple first sports medicine procedures in Australia and the U.S.
A Wright Medical shareholder filed a suit against Wright, its board and Stryker, claiming that the Solicitation Statement submitted to shareholders in association with the proposed acquisition is false and misleading.
Embody is receiving a $2.5 million Phase II research award. Funds will support development and clinical assessment of collagen-based MICROBRACE™ ACL technology for anterior cruciate ligament repair.
OrthoSensor and McLaren Applied formed EnMovi to expand development of MOTIONSENSE™ wearable sensor technology and ORTHOLOGIQ® data analytics for use in orthopedic patient care.